Kiran Devisetty, MD, FASTRO

Thank you to our 🔥 panelists! Dr. Sushil Beriwal, @tomboike, @KiranDevisetty, & @tjroycemd. Amazing insight into careers in industry and the overlap with clinical roles. We are still clinicians at the end of the day! 🥼 Had so much fun moderating!! @ARRO_org @ASTRO_org #ARRODay

Presented at #SABCS24: Interim results from the EUROPA trial: Single-modality #endocrinetherapy vs #radiotherapy after breast-conserving surgery in women aged 70 years and older with luminal A-like early #breastcancer thelancet.com/journals/lanon…

@WashUMedRadOnc @SBRT_CR @WUSTL @jmmrad @JulieSchwarz14 @samsonpp @DoctorPhillEP @MikeWaters121 @carmenbergom @SMarkovina2 @gdhugo @ASTRO_org @SitemanCenter Congratulations, Cliff!!!

Congratulations to our amazing Chief of SBRT & Assoc Director of Clinical Programs @SBRT_CR -- he has been granted tenure by the @WUSTL Board of Trustees! source.washu.edu/2024/10/board-…

Young Doctors Want Work-Life Balance. Older Doctors Say That’s Not the Job. - #WSJ wsj.com/lifestyle/care…

Brilliant @JCOOP_ASCO perspective piece by the estimable @RTendulkarMD on how to find the right meaning & balance in medical practice today. This advice translates to life & #leadership in general, so a must read for all. #medicine #goldenrule #empathy ascopubs.org/doi/full/10.12…

So proud of my former colleagues @ClevelandClinic co-residents, & med school classmates @UMich honored at #ASTRO24!

Fascinating news regarding #xevinapant in #hncsm emdgroup.com/en/news/xevina…

Absolutely terrific thread here on ENI dosing for oropharyngeal cancer, touching not just on recent data but on how new standards are established. Just a few thoughts on top of well-articulated arguments for different approaches. (1/n)

ADRIATIC study is the new standard of care for limited stage small cell lung cancer followed by adjuvant durvalumab with improved mOS to 56 mo from 33 mo (placebo) and mPFS of 17 months with durvalumab vs 9 mo (placebo) #ASCO24

⁦An insightful @WSJ⁩ perspective piece on #financialtoxicity for #oncology patients. wsj.com/health/healthc…

🚨🚨RTOG 0848🚨🚨 Anatomically resectable PDAC randomized postoperatively 1st randomization: Gemcitabine +/- erlotinib (no benefit with erlotinib) 🔥2nd Randomization🔥 +/- Chemoradiation, 50.4 Gy/28 fx + cape ✅⬆️ DFS w/ ☢️ ✅N0, ⬆️DFS and OS (5y 48% vs 29%) w/ ☢️ #asco24

@IBCradiation One thing is for sure, I’d be less likely to omit RT for low ER+! 10y local failure of 18.8% on PRIME2 😳 (read: most favorable candidates for omission. >= 65y, < 3 cm (only 10% 2-3 cm), pN0, SM >= 1mm, G1-2 (only 3% G3), LVSI (4%), G3 AND LVSI excluded)

A thoughtful oncologist perspective in @JAMAOnc on what it can feel like at a time of a potential oncologic diagnosis and that even the most favorable prognosis does not bring much comfort. jamanetwork.com/journals/jamao…

Excellent and concise @NEJM editorial on the theoretical benefits and actual risks of health care vertical integration. nejm.org/doi/full/10.10…

Reconciling the discrepancies in randomized data of combining immunotherapy and radiation therapy: Not all radiotherapy is created equal, published in Europe Journal of Cancer today. Here is the personalized Share Link:
authors.elsevier.com/a/1ihIj_Lqip9w…

@HenningWillers @theNCI @RRS_RadRes @ASTRO_org @_MichaelBaumann @SorenBentzen @rweichselbaum @TedHong9 @KrauseProf @gillies_mckenna @StevenLin_MDPhD @NCICTEP_ClinRes His energy was boundless, his curiosity was endless, his kindness was limitless. I was honored to have worked with him at the NCI.

Terribly sad that Norm Coleman of RRP @theNCI passed away😢 He was just a terrific human being & absolute giant in our field of #radonc #radbio #globaloncology I have always appreciated his tremendous support over the years, his insights & his wit! Enjoyed #ASTRO23 5K with him🙏

Beautiful ⁦@JCO_ASCO⁩ piece that resonated with my 10 yrs in #rural #oncology. The patients (and their families) with whom I worked were the kindest and most grateful in my career. I was lucky to be a part of their journey. ascopubs.org/doi/10.1200/OP…

A must listen on the physical/mental/spiritual stresses physicians must endure - and learn how to handle - during their career journey while striving to heal their patients. twitter.us16.list-manage.com/track/click?u=…

1/N Finally out!! -- 30Gy for HPV+OPC in @JCO_ASCO – work by the @MSKCancerCenter Head and Neck team, led by @imrtlee, Eric Sherman, and myself on using hypoxia imaging response to cut treatment 60% (70->30Gy)! #radonc #hncsm ascopubs.org/doi/10.1200/JC…